Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Rectal Neoplasms 1Neoplasms 1Colonic Neoplasms 1Adenoma 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Occult Blood × 1 year × Clear all
NCT01538550 2026-04-14

Pilot Study of a National Screening Programme for Bowel Cancer in Norway

Norwegian Institute of Public Health

Phase NA Active not recruiting
140,000 enrolled
Gastrointestinal

Adenoma, Neoplasms, Colorectal Neoplasms

NCT00102011 2026-03-09

00-046

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
4,952 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡